Page last updated: 2024-12-05

pyocyanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pyocyanine is a blue-green pigment produced by Pseudomonas aeruginosa, a bacterium commonly found in soil, water, and the human respiratory tract. It is synthesized via a complex pathway involving multiple enzymes and intermediates. Pyocyanine exhibits a range of biological activities, including antimicrobial, cytotoxic, and immunomodulatory effects. It has been shown to inhibit the growth of other bacteria and fungi, as well as to kill cancer cells. Pyocyanine is also known to induce oxidative stress and inflammation, which can contribute to the pathogenesis of P. aeruginosa infections. Due to its biological activity and potential role in disease, pyocyanine has been extensively studied. Research efforts focus on understanding its mechanism of action, its role in P. aeruginosa virulence, and its potential as a therapeutic target.'

Pyocyanine: Antibiotic pigment produced by Pseudomonas aeruginosa. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pyocyanine : An iminium betaine that is 5-methylphenazin-5-ium which is substituted at position 1 by an oxidanidyl group. An antibiotic pigment produced by Pseudomonas aeruginosa. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6817
CHEMBL ID2289232
SCHEMBL ID689070
SCHEMBL ID19996638
MeSH IDM0018213

Synonyms (48)

Synonym
phenazinium, 5-methyl-1-hydroxy-, inner salt
SG16430000
4738-b
niosh/sg1643000
antibiotic 4738-b
cyanomycin
5-methyl-1-hydroxyphenazinium inner salt
5-methyl-phenazin-5-ium-1-olate
pyrocyanine
nsc-400612
nsc400612
sanazin
phenazinium, hydroxide, inner salt
1(5h)-phenazinone, 5-methyl-
sanasin
85-66-5
5-methylphenazin-5-ium-1-olate
pyocyanine
5-methylphenazin-1(5h)-one
pyocyanin
5-methylphenazin-1-one
FT-0652107
AKOS003625584
phenazinium, 1-hydroxy-5-methyl-, hydroxide, inner salt
unii-9oqm399341
nsc 400612
9oqm399341 ,
1(5h)-phenazinone, 5-methyl- (van)
pyocyanine (van)
5-methyl-1(5h)-phenazinone
SCHEMBL689070
CHEMBL2289232
pyocyanine [mi]
HMS3650O18
DTXSID9041108
pyocyanin, from pseudomonas aeruginosa, >=98% (hplc)
YNCMLFHHXWETLD-UHFFFAOYSA-N
SCHEMBL19996638
pyocyanin; pyrocyanine; sanasin; sanazin
Q410503
5-methyl-1,5-dihydrophenazin-1-one
SR-01000946315-1
sr-01000946315
pyocyanin; pyocyanine; sanasin
CS-0034807
HY-111278
AS-82218
EN300-7471116

Research Excerpts

Actions

ExcerptReferenceRelevance
"Pyocyanine was able to cause the oxidation of reduced nicotinamide adenine dinucleotide, with O2- production, in the absence of enzymatic catalysis."( Mechanism of the antibiotic action pyocyanine.
Fridovich, I; Hassan, HM, 1980
)
1.26

Toxicity

ExcerptReferenceRelevance
" On oxidation, polyphenols with B-ring catechol functionality form toxic alkylating quinones that are normally inactivated by cellular antioxidant defense and redox maintenance systems, including reduction by ascorbate and NAD(P)H:quinone oxidoreductase 1 (NQO1)."( Polyphenol cytotoxicity induced by the bacterial toxin pyocyanin: role of NQO1.
Muller, M, 2009
)
0.35
"It is widely recognized that bacterial metabolites have toxic effects in animal systems."( Phenazine derivatives cause proteotoxicity and stress in C. elegans.
Caldwell, GA; Caldwell, KA; Ray, A; Rentas, C, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" The objective of this study was to determine whether pyocyanin reduces Ag+ to Ag0, which may contribute to silver resistance due to lower bioavailability of the cation."( Pyocyanin production by Pseudomonas aeruginosa confers resistance to ionic silver.
Merrett, ND; Muller, M, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Pyo (10 microM) surmountably inhibited aortic responses to GTN, isosorbide dinitrate, SIN-1, and SNAP with a characteristic rightward shift of the dose-response curve; the apparent EC50 of these drugs for relaxation of phenylephrine-contracted aorta was increased 18-, 4-, 13-, and 15-fold, respectively."( Inhibition of nitrovasodilators by pyocyanin and methylene blue is dissociated from nitric oxide formation.
Bozinovski, J; Brien, JF; Marks, GS; Nakatsu, K, 1994
)
0.29
" In parallel, the gacA gene dosage markedly influenced the BHL/RhIR-dependent formation of the cytotoxic compounds pyocyanin and cyanide and the exoenzyme lipase."( The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase.
Beyeler, M; Foglino, M; Haas, D; Latifi, A; Lazdunski, A; Reimmann, C; Winteler, H, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
biological pigmentAn endogenous molecular entity that results in a colour of an organism as the consequence of the selective absorption of light.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
virulence factorAny toxin secreted by bacteria, viruses, fungi or protozoa enabling them to achieve colonisation of a niche in the host, inhibit or evade the host's immune response, enter and exit cells, or obtain nutrition from the host.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenazinesAny organonitrogen heterocyclic compound based on a phenazine skeleton and derivatives.
iminium betaine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID1519551Displacement of [3H]-LSD from human recombinant 5HT2B receptor expressed in stable HEK cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519567Displacement of [3H]-Muscimol from GABAA receptor in rat brain incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519568Displacement of [3H]-DADLE from human recombinant DOR receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519580Displacement of [3H]-PK11195 from PBR in rat brain incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519581Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519548Displacement of [3H]-5-CT from human recombinant 5HT1D receptor expressed in HEKT cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519565Displacement of [3H]-SCH23390 from human recombinant dopamine D5 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519569Displacement of [3H]-U69593 from human recombinant KOR receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519562Displacement of [3H]-N-methylspiperone from human recombinant dopamine D2 receptor expressed in stable fibroblast cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519571Displacement of [3H]-Pyrilamine from human recombinant histamine H1 receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519563Displacement of [3H]-N-methylspiperone from human recombinant dopamine D3 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519550Displacement of [3H]-ketanserin from human recombinant 5HT2A receptor expressed in HEKT cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519555Displacement of [3H]-8-OH-DPAT from human recombinant alpha1B adrenergic receptor expressed in HEKT cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519564Displacement of [3H]-methylspiperone from human recombinant dopamine D4 receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519553Displacement of [3H]-GR65630 from human recombinant 5HT3 receptor expressed in HEKT cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519566Displacement of [3H]-Win35428 from human recombinant DAT receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519573Displacement of [3H]-alpha-methylhistamine from human recombinant histamine H3 receptor expressed in Flp-In HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1525366Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 16 to 20 hrs by CLSI protocol based broth microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID1519531Displacement of [3H]-QNB/[3H]-NMS from human recombinant muscarinic acetylcholine M1 receptor expressed in stable CHO cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519554Displacement of [3H]-prazosin from human recombinant alpha1A adrenergic receptor at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519576Displacement of [3H]-QNB/[3H]-NMS from human recombinant muscarinic acetylcholine M3 receptor expressed in stable CHO cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1113018Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 hr by inverted microscopic analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID1519560Displacement of [3H]-Flunitrazepam from BZP receptor in rat brain at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519570Displacement of [3H]-DAMGO from human recombinant MOR receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519549Displacement of [3H]-5-HT from human recombinant 5HT1E receptor expressed in stable HEK cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519557Displacement of [125I]-pindolol from recombinant human beta1 adrenergic receptor expressed in CHO Flp-In cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519583Displacement of [3H]-citalopram from recombinant human SERT expressed in HEK cell membranes at 10 uM incubated for 90 mins by scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519578Displacement of [3H]-QNB/[3H]-NMS from human recombinant muscarinic acetylcholine M5 receptor expressed in stable CHO cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519556Displacement of [3H]-8-OH-DPAT from human recombinant alpha1D adrenergic receptor at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519561Displacement of [3H]-SCH23390 from human recombinant dopamine D1 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519574Displacement of [3H]-Histamine from human recombinant histamine H4 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519575Displacement of [3H]-QNB/[3H]-NMS from human recombinant muscarinic acetylcholine M2 receptor expressed in stable CHO cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519572Displacement of [125I]-Iodoaminopotentidine from human recombinant histamine H2 receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1113017Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 day by inverted microscopic analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID1519552Displacement of [3H]-Mesulergin from human recombinant 5HT2C receptor expressed in CHO cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519577Displacement of [3H]-QNB/[3H]-NMS from human recombinant muscarinic acetylcholine M4 receptor expressed in stable CHO cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519546Displacement of [3H]-8-OH-DPAT from human recombinant 5HT1A receptor expressed in stable CHO cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519559Displacement of [3H]-CGP12177 from human recombinant adrenergic beta3 receptor expressed in Flp-In HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519558Displacement of [125I]-CGP12177 from recombinant human beta2 adrenergic receptor expressed in HEK Flp-In cells measured after 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519547Displacement of [3H]-5-CT from human recombinant 5HT1B receptor expressed in stable HEK cells at 10 uM incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519533Cytotoxicity against mouse NIH/3T3 cells measured after 72 hrs by MTT assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519579Displacement of [3H]-Nisoxetine from human recombinant NET receptor expressed in stable HEK cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1519532Cytotoxicity against mouse NIH/3T3 cells measured after 48 hrs by MTT assay2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
AID1525365Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 20 hrs by CLSI protocol based broth microdilution method2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.
AID1519582Displacement of [3H]-CTG from human recombinant sigma2 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method2020European journal of medicinal chemistry, Jan-01, Volume: 185Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (686)

TimeframeStudies, This Drug (%)All Drugs %
pre-199080 (11.66)18.7374
1990's56 (8.16)18.2507
2000's107 (15.60)29.6817
2010's303 (44.17)24.3611
2020's140 (20.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.19 (24.57)
Research Supply Index6.56 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index83.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.14%)5.53%
Reviews27 (3.84%)6.00%
Case Studies3 (0.43%)4.05%
Observational0 (0.00%)0.25%
Other672 (95.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]